322 related articles for article (PubMed ID: 9312191)
1. Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin.
Kane C; Lindley KJ; Johnson PR; James RF; Milla PJ; Aynsley-Green A; Dunne MJ
J Clin Invest; 1997 Oct; 100(7):1888-93. PubMed ID: 9312191
[TBL] [Abstract][Full Text] [Related]
2. [Persistent hyperinsulinemic hypoglycemia of infancy (PHHI)].
Yamada Y
Nihon Rinsho; 1997 Nov; 55 Suppl():900-3. PubMed ID: 9434584
[No Abstract] [Full Text] [Related]
3. Compound heterozygosity for the common sulfonylurea receptor mutations can cause mild diazoxide-sensitive hyperinsulinism.
Dekel B; Lubin D; Modan-Moses D; Quint J; Glaser B; Meyerovitch J
Clin Pediatr (Phila); 2002 Apr; 41(3):183-6. PubMed ID: 11999683
[TBL] [Abstract][Full Text] [Related]
4. Loss of functional KATP channels in pancreatic beta-cells causes persistent hyperinsulinemic hypoglycemia of infancy.
Kane C; Shepherd RM; Squires PE; Johnson PR; James RF; Milla PJ; Aynsley-Green A; Lindley KJ; Dunne MJ
Nat Med; 1996 Dec; 2(12):1344-7. PubMed ID: 8946833
[TBL] [Abstract][Full Text] [Related]
5. Congenital hyperinsulinism: molecular basis of a heterogeneous disease.
Meissner T; Beinbrech B; Mayatepek E
Hum Mutat; 1999; 13(5):351-61. PubMed ID: 10338089
[TBL] [Abstract][Full Text] [Related]
6. Familial hyperinsulinism and pancreatic beta-cell ATP-sensitive potassium channels.
Sharma N; Crane A; Gonzalez G; Bryan J; Aguilar-Bryan L
Kidney Int; 2000 Mar; 57(3):803-8. PubMed ID: 10720932
[TBL] [Abstract][Full Text] [Related]
7. Molecular biology of adenosine triphosphate-sensitive potassium channels.
Aguilar-Bryan L; Bryan J
Endocr Rev; 1999 Apr; 20(2):101-35. PubMed ID: 10204114
[TBL] [Abstract][Full Text] [Related]
8. Engineering a glucose-responsive human insulin-secreting cell line from islets of Langerhans isolated from a patient with persistent hyperinsulinemic hypoglycemia of infancy.
MacFarlane WM; Chapman JC; Shepherd RM; Hashmi MN; Kamimura N; Cosgrove KE; O'Brien RE; Barnes PD; Hart AW; Docherty HM; Lindley KJ; Aynsley-Green A; James RF; Docherty K; Dunne MJ
J Biol Chem; 1999 Nov; 274(48):34059-66. PubMed ID: 10567373
[TBL] [Abstract][Full Text] [Related]
9. Successful therapy with calcium channel blocker (nifedipine) in persistent neonatal hyperinsulinemic hypoglycemia of infancy.
Baş F; Darendeliler F; Demirkol D; Bundak R; Saka N; Günöz H
J Pediatr Endocrinol Metab; 1999; 12(6):873-8. PubMed ID: 10614546
[TBL] [Abstract][Full Text] [Related]
10. Characterization of genes encoding the pancreatic beta-cell ATP-sensitive K+ channel in persistent hyperinsulinemic hypoglycemia of infancy in Japanese patients.
Someya T; Miki T; Sugihara S; Minagawa M; Yasuda T; Kohno Y; Seino S
Endocr J; 2000 Dec; 47(6):715-22. PubMed ID: 11228046
[TBL] [Abstract][Full Text] [Related]
11. Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes.
Service FJ; Natt N; Thompson GB; Grant CS; van Heerden JA; Andrews JC; Lorenz E; Terzic A; Lloyd RV
J Clin Endocrinol Metab; 1999 May; 84(5):1582-9. PubMed ID: 10323384
[TBL] [Abstract][Full Text] [Related]
12. [PHHI (persistent hyperinsulinemic hypoglycemia of infancy)].
Nagashima K
Nihon Rinsho; 2002 Oct; 60 Suppl 10():637-40. PubMed ID: 12430295
[No Abstract] [Full Text] [Related]
13. Loss of imprinted genes and paternal SUR1 mutations lead to hyperinsulinism in focal adenomatous hyperplasia.
Fournet JC; Verkarre V; De Lonlay P; Rahier J; Brunelle F; Robert JJ; Nihoul-Fékété C; Saudubray JM; Junien C
Ann Endocrinol (Paris); 1998; 59(6):485-91. PubMed ID: 10189991
[TBL] [Abstract][Full Text] [Related]
14. Histochemical, clinical, and in vitro beta cell responses in a neonate with persistent hyperinsulinaemic hypoglycaemia of infancy.
Panesar NS; Poon CW; Liew CT; Wong GW; Hjelm NM
Arch Dis Child Fetal Neonatal Ed; 1998 Sep; 79(2):F141-4. PubMed ID: 9828742
[TBL] [Abstract][Full Text] [Related]
15. A new familial form of a late-onset, persistent hyperinsulinemic hypoglycemia of infancy caused by a novel mutation in KCNJ11.
Yang YY; Long RK; Ferrara CT; Gitelman SE; German MS; Yang SB
Channels (Austin); 2017 Nov; 11(6):636-647. PubMed ID: 29087246
[TBL] [Abstract][Full Text] [Related]
16. Preoperative use of octreotide in a newborn with persistent hyperinsulinemic hypoglycemia of infancy.
Apak RA; Yurdakök M; Oran O; Senocak ME; Cağlar M
J Pediatr Endocrinol Metab; 1998 Mar; 11 Suppl 1():143-5. PubMed ID: 9642652
[TBL] [Abstract][Full Text] [Related]
17. A selective nonpeptide somatostatin receptor 5 agonist effectively decreases insulin secretion in hyperinsulinism.
Juliana CA; Chai J; Arroyo P; Rico-Bautista E; Betz SF; De León DD
J Biol Chem; 2023 Jun; 299(6):104816. PubMed ID: 37178920
[TBL] [Abstract][Full Text] [Related]
18. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy.
Thomas P; Ye Y; Lightner E
Hum Mol Genet; 1996 Nov; 5(11):1809-12. PubMed ID: 8923010
[TBL] [Abstract][Full Text] [Related]
19. An autosomal dominant form of familial persistent hyperinsulinemic hypoglycemia of infancy, not linked to the sulfonylurea receptor locus.
Kukuvitis A; Deal C; Arbour L; Polychronakos C
J Clin Endocrinol Metab; 1997 Apr; 82(4):1192-4. PubMed ID: 9100595
[TBL] [Abstract][Full Text] [Related]
20. The enigma of persistent hyperinsulinemic hypoglycemia of infancy.
Daneman D; Ehrlich RM
J Pediatr; 1993 Oct; 123(4):573-5. PubMed ID: 8410509
[No Abstract] [Full Text] [Related]
[Next] [New Search]
